Bjursten, Henrik
Norrving, Bo
Ragnarsson, Sigurdur
Funding for this research was provided by:
Swedish National ALF-funds
Regional research funds regions Skåne
Heart-Lung Foundation
Färs och Frosta Sparbank
Lund University
Article History
Received: 10 February 2021
Accepted: 22 April 2021
First Online: 5 May 2021
Competing interests
: HB has served as a consultant for Boston Scientific and Edwards Lifescience. BN has received fees from Astra Zeneca and Bayer for work in data monitoring committees in the SOCRATES, THALES and NAVIGATE-ESUS trials. SR does not have any relevant conflict of interest to report.